Business Context and Reporting Period
Company: Manhattan Associates, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 28, 2025
Reporting Period: The filing announces financial results for the three and twelve months ended December 31, 2024. The specific numerical results are contained in a press release attached as Exhibit 99.1 and are not detailed within the text of this 8-K form.
Key Financial Metrics
The text of this filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) containing these figures. The filing does, however, define the company's Non-GAAP financial measures used in that press release:
- Adjusted Results: Include adjusted operating income, margin, income tax provision, net income, and diluted earnings per share.
- Exclusions: These measures exclude equity-based compensation, expenses related to an unusual health insurance claim, and related income tax effects.
- Rationale: Equity-based compensation is excluded as it typically does not require cash settlement. The health insurance claim is excluded due to its uncommonly large magnitude and nature, which management deems not typical of normal operating activities.
Material Changes
The filing text does not provide specific comparative data or quantify material changes versus prior periods. It notes that management uses adjusted results to facilitate internal comparisons to historical operating results and comparisons to competitors.
Guidance, Outlook, and Management Commentary
Management Commentary:
- Management utilizes adjusted results for internal reporting, compensation planning, and executive bonus plans.
- These measures are considered primary for reviewing management team performance and making operating decisions regarding R&D investment, capital expenditures, and acquisitions.
- Management believes these measures provide meaningful supplemental information for investors to evaluate operating trends and compare performance with industry peers.
- The filing text does not contain specific forward-looking guidance, outlook figures, or a detailed discussion of risks and contingencies beyond the definition of the unusual health insurance claim.
- Unusual Health Insurance Claim: Identified as a significant expense excluded from Non-GAAP results due to its magnitude and non-recurring nature.
Important Facts for Investor Verification
- Source of Data: Verify specific revenue, profit, and cash flow numbers in the attached Press Release (Exhibit 99.1), as they are not listed in the 8-K text.
- Non-GAAP Reconciliation: Review the reconciliation between GAAP and Non-GAAP measures in the press release to understand the exact financial impact of the excluded equity-based compensation and the unusual health insurance claim.
- Claim Details: Investigate the nature and total cost of the "unusual health insurance claim" to assess potential future liability or recurrence risks.
- Year-End Performance: Confirm the full-year 2024 performance metrics against the company's prior guidance and analyst expectations.